EP Biocomposites Ltd

EP Biocomposites Other Announcement

This filing submits the quarterly shareholding pattern for EP Biocomposites Ltd as required under Regulation 31(1)(b) of SEBI LODR Regulations.

EP Biocomposites Partnership

EP Biocomposites signed a strategic collaboration and consultancy agreement with Malligavad Foundation and Anand Malligavad for water conservation projects, with no upfront monetary consideration.

EP Biocomposites Bags ₹0.92 Cr Order from Beleza by the Beach

EP Biocomposites Limited secured a ₹0.92 Crore order from Beleza by the Beach to install a 70 KLD Sewage Treatment Plant by April 2027.

Value

₹0.92 Cr

From

Beleza by the Beach

Execution

30.04.2027

Sewage Treatment Plant

70.0 KLD

EP Biocomposites Annual General Meeting

EP Biocomposites has shared the draft Chairman’s speech for its 7th Annual General Meeting on September 28, 2026. It highlights recent financial performance and strategic initiatives.

EP Biocomposites Investor Presentation: Key Takeaways

EP Biocomposites Limited reported FY26 revenue of ₹1,363.98 lakhs with a 10.69% PAT margin. The company is pivoting towards sustainable infrastructure solutions including bio-digesters and wastewater treatment.

EP Biocomposites Annual Report

EP Biocomposites Ltd has released its 7th Annual Report for the financial year 2025-26, detailing operational highlights and financial performance snapshots.

EP Biocomposites Annual General Meeting

EP Biocomposites Ltd has issued a notice for its 7th Annual General Meeting, scheduled for September 28, 2026, to discuss financial statements and director appointments.

EP Biocomposites Other Announcement

EP Biocomposites Ltd filed its quarterly shareholding pattern statement for the period ending June 30, 2026, as required by regulatory norms.

EP Biocomposites Results Update

EP Biocomposites reported ₹13.64 Crore revenue for FY26, with PAT surging 41.5% YoY. Strong growth momentum reflects successful IPO utilization and operational excellence.

Value

₹13.64 Cr

EP Biocomposites H2 FY26 Results: Net Profit ₹1.4 Cr, Up 75.0% YoY

EP Biocomposites Ltd reported revenue from operations of ₹9.6 Cr (+26.3% YoY) and net profit of ₹1.4 Cr (+75.0% YoY) for H2 FY26.

Key figure

Net profit ₹1.4 Cr · +75.0% YoY

EP Biocomposites Financial Results

EP Biocomposites Ltd reported a total annual income of ₹13.78 Crore for FY26. Net profit stood at ₹1.46 Crore, showing consistent growth over previous periods.

Value

₹13.78 Cr

EP Biocomposites Board Meeting Date

EP Biocomposites Ltd scheduled a board meeting for May 26, 2026, to approve audited financial results. The trading window remains closed for designated persons.